CHAPTER 8
Use and Misuse of Central Nervous System Stimulants
LEARNING OBJECTIVES
After studying this chapter, students should be able to:
•
8.1: Understand the current medical use of stimulants
•
8.3: Comprehend the current misuse of stimulants, including the methods
of use and the effects
•
8.5: Understand the DSM criteria for stimulant-related disorders
CHAPTER OUTLINE
CNS Stimulants as Used in Medical Practice
The Amphetamine-Like Drugs
The Amphetamine Compounds
Subjective Experience of Amphetamine Use in Medical Practice
Challenges to the Use of CNS Stimulants to Treat Identified Disorders
CNS Stimulant Misuse
Scope of the Problem
Methods of CNS Stimulant Misuse and Their Effects
CNS Stimulant Misuse and the Diagnostic and Statistical Manual of Mental Disorders (5th
Edition)
CHAPTER OVERVIEW
The main purpose of this chapter is to review the history of the central nervous system (CNS)
stimulants and how they are used both by physicians and by those who misuse substances.
Thus, this chapter is split into two sections: In the first section, the medical use of these
compounds, their subjective effects, complications induced by their medicinal use, and the
challenges to their continued use will be reviewed. The second section is devoted to the misuse
of CNS stimulants, the incentives for their use, and the consequences of their misuse.
DISCUSSION QUESTONS
Break-Out Discussion #1:
Ephedrine as a legal drug: Because of a historical accident, ephedrine was introduced in an era
between the Pure Food and Drug Act of 1906, which required that manufacturers only identify
the ingredients of a compound that was sold as a medicine, and the Food, Drug, and Cosmetic
Act of 1938. This second law, passed in response to a disaster in which a toxin accidentally
The Durham-Humphrey Amendment to the Food, Drug, and Cosmetic Act of 1938 was passed in